www.camurus.com Open in urlscan Pro
52.174.176.76  Public Scan

Form analysis
1 forms found in the DOM

/search/

<form action="/search/">
  <input aria-label="Search" class="_searchbox" placeholder="Search" name="q" value="" autocomplete="off"><button aria-label="Submit search"></button>
  <div class="_instantsearch" data-nohits="No results found"></div>
</form>

Text Content

Skip to main contentSkip to navigationSkip to search
 * About us
   
   * Contact us
   
   * About us
   
   * Our commitment
   * Business model
   * Board of directors
   * Management team
   * Code of conduct
 * Science
   
   * 
   
   * Science
   
   * Products
   * R&D pipeline
   * Technology
 * Disease areas
   
   * Read Will's story
   
   * Disease areas
   
   * Opioid dependence
   * Acromegaly
   * Polycystic liver disease
   * Neuroendocrine tumors
 * Sustainability
 * Investors
   
   * 
   
   * Investors
   
   * The share
   * Press releases
   * Financial reports
   * Events and presentations
     * Capital Markets Day
   * Corporate governance
     * Committees
     * Remuneration
     * General meetings
     * Auditors
     * Incentive programs
     * Articles of association
     * Nomination Committee
     * AGM
   * General meetings
   * CEO message
   * IPO and Prospectus
   * Investor contact
 * Partnering
 * Media
   
   * 
   
   * Media
   
   * Press releases
   * Media contact
   * Media archive
 * Career
 * Contact


English
EnglishSvenska




DELIVERING BETTER TREATMENTS

Camurus is committed to improving the lives of patients
with severe and chronic diseases

Read more


UPDATES


LATEST NEWS

All press releases

23 November 2022


CAMURUS ANNOUNCES THAT BRAEBURN RESUBMITS NDA FOR BRIXADI™ IN THE US

Press release
11 November 2022


CAMURUS TO PRESENT AT JEFFERIES 2022 HEALTHCARE CONFERENCE LONDON

Press release
10 November 2022


CAMURUS’ INTERIM REPORT THIRD QUARTER 2022

Regulatory

All press releases

Disease areas


FOCUS ON SEVERE AND CHRONIC DISEASES

Developing treatments for diseases within the central nervous system, rare
diseases, endocrinology, oncology and supportive care

Learn more on disease areas

Events


UPCOMING EVENTS


See all events

 * 12 Dec
   
   
   DNB NORDIC HEALTHCARE CONFERENCE
   
   Camurus’ President & CEO Fredrik Tiberg is presenting at this conference in
   Oslo, Norway, 15 December, 2022 at 12.35pm CET. The presentation can be seen
   by the conference participants.
   
   Add to calendar

 * 14 Feb
   
   
   FULL YEAR REPORT 2022
   
   The full year report 2022 is published on 14 February 2023.
   
   Add to calendar

 * 30 Mar
   
   
   ANNUAL REPORT 2022
   
   The Annual Report 2022 is published on 30 March 2023.
   
   Add to calendar





Latest financial report


CAMURUS’ INTERIM REPORT THIRD QUARTER 2022

10 November 2022

 * Report Camurus’ Interim Report Third Quarter 2022
 * Presentation Camurus’ Interim Report Third Quarter 2022
 * Audiocast Camurus’ Interim Report Third Quarter 2022

Go to report archive



Products




ADDRESSING IMPORTANT UNMET MEDICAL NEEDS

Learn about our products

Stories




LIVING WITH OPIOID DEPENDENCE

Read Will's story

Pipeline


DIVERSIFIED PIPELINE WITH LARGE POTENTIAL

Camurus' innovative product candidates are designed to address important unmet
medical needs, with the potential to make significant difference in the daily
life of patients by improving treatment outcomes, quality of life, and long-term
recovery.

See pipeline

sustainability


SUSTAINABLE SOLUTIONS FOR A HEALTHIER WORLD

Ensuring the long-term successful development of our business – for the benefit
of patients, healthcare systems, employees and shareholders

Learn more






QUICKLINKS

 * Contact
 * About us
 * Pipeline
 * Products


INVESTORS

 * Press releases
 * Financial reports
 * IR contact


ADDRESS

Camurus AB
Ideon Science Park
SE-223 70 Lund, Sweden




 * Terms of Use
 * Privacy notice
 * Cookie policy

Camurus AB - all rights reserved
English
EnglishSvenska

This website uses cookies to provide the best possible user experience. By
accepting you consent to cookies being used. Read more about cookies here

Accept